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Target audience: Researchers investigating fetal brain development.  
Purpose: Retrospective motion correction is now possible for fetal brain MRI 
at the 2nd and 3rd trimester, making it possible to quantify early human brain 
development in utero. When combined with appropriate image analysis 
techniques, this allows reliable measurement of human fetal brain growth. In 
the present study, the Isotropic Cavalieri1 method has been applied to analyse 
fetal brain 3D reconstructions in order to measure growth of brain in fetuses 
exposed to maternal substance abuse (methodone, diazepam and trazadone) 
compared to non-exposed fetuses.  
Methods: Scanning: Following ethics committee approval, 46 healthy pregnant 
women were recruited and scanned on a 3 T Siemens MAGNETOM Verio at 24–
27 weeks’ (Visit 1; 26 women) and 36–38 weeks’ (Visit 2; 38 women, 18 
returned from first scan) gestation. Non-breath-hold, multi-slice, HASTE 
acquisitions were acquired three times in each of axial, sagittal and coronal 
scanning directions (25–50 slices, TE = 94 ms, 0.55 × 0.55 × 3 mm3 voxels). The 
image series were motion corrected and reconstructed to form a single 3D high 
resolution brain image (1 × 1 × 1 mm3) using the 
Slice MRI Motion Estimation and Reconstruction 
(SLIMMER) tool2, with motion corrected data rated 
based on image quality (Figure 1). The resulting 3D 
datasets were used to estimate fetal brain 
intracranial, cerebellum and cerebral volumes, and 
arachnoid and pial surface areas (intracranial and 
cerebellum surface areas) using Isotropic Cavalieri1 
in Analyze 10.0 (MAYO Foundation, USA). 
Results and Discussion: Details regarding the 
success of the motion correction algorithm are 
presented in Table 1. Reconstruction of fetal brain 
was not possible in 7 fetuses (27%) and poor in 6 
fetuses (23%) from 2nd trimester and poor in 2 
fetuses (5%) from 3rd trimester due to 
excessive fetal motion and bias field 
inhomogeneity. Movement was generally 
greater and more challenging to correct for 
during the 2nd trimester than the 3rd. So far, 
brain volume and surface area analyses are 
only conducted for data from 36–38 weeks; 
measurements were only possible for brain 
images rated A, B and C. The effect of 
exposure on fetal brain growth was assessed 
using a general linear univariate model based 
on one between-subject variable for all of the 
volume and surface area measurements. Two 
covariates were included in all analyses: 
gestational age at scan and birth weight. 
Fetuses exposed to maternal substance abuse 
showed significant reduction in intracranial 
volume (p = 0.03) and cerebral volume (p < 
0.03), with this effect being greater on male 
fetuses’ intracranial volumes. Although a similar trend can be seen for cerebellum volume and arachnoid and pial surface areas, these did not 
reach statistical significance. The cerebellum volume and pial surface area in female fetuses exposed to maternal substance abuse is 
significantly smaller compared to male exposed fetuses (p < 0.03 and p < 0.02, respectively).  
Conclusion: Fetal intracranial and cerebral volumes were reduced by maternal substance abuse.  
Future Work: The analyses of motion corrected 3D fetal brain images will be conducted for data from 24–27 weeks. Analyses will be 
extended to include measurement of sub-regions of the fetal brain by adapting a variety of image analysis techniques, mainly semi-automatic 
segmentation methods based on edge detection, to study the growth in fetuses exposed to maternal substance abuse across gestation. This 
technique will be used to investigate the reliability of fetal brain measurements using the Isotropic Cavalieri method.  
References: [1] Cruz-Orive LM, et al. (2010) J Microsc, 240 (2): 94-110, [2] Kim K, et al. (2010), IEEE Trans. Med. Imaging, 29 (1): 146-158. 
Figure 1: Image quality grading of motion corrected fetal 
brain images in the axial plane at 2nd (top row) and 3rd 
(bottom row) trimester: best (A), good (B), moderate 
(C), poor (D) and reconstruction failed (E). 
Table 1: Details of the quality of motion corrected data at each gestation. 
Figure 2: Effect of maternal substance abuse on fetal brain (intracranial, cerebral and 
cerebellum volumes, arachnoid and pial surface areas). 
